GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Feb 2019 123

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

Scope of the Report:
The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests, Imaging, Biopsy and other, and most of Prostate Cancer Diagnostics use the method of Biopsy, the proportion of Biopsy in 2017 is about 44.65%.
Prostate Cancer Diagnostics is widely used for the people with Prostate Cancer, The most proportion of Prostate Cancer Diagnostics is used for people with the age between 55 and 75, and the proportion is about 70.24% in 2017.
North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49.84% in 2017. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28% in 2017.
The worldwide market for Prostate Cancer Diagnostics is expected to grow at a CAGR of roughly 7.9% over the next five years, will reach 15800 million US$ in 2024, from 10000 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Prostate Cancer Diagnostics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Genomic Health
- Abbott
- OPKO
- Siemens Healthcare
- DiaSorin
- BioMeriux
- Roche
- MDx Health
- Beckman Coulter
- Myriad Genetics
- Ambry Genetics

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Tumor Biomarker Tests
- Imaging
- Biopsy
- Other

Market Segment by Applications, can be divided into
- age < 55
- age 55-75
- age > 75

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostate Cancer Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prostate Cancer Diagnostics, with price, sales, revenue and global market share of Prostate Cancer Diagnostics in 2017 and 2018.
Chapter 3, the Prostate Cancer Diagnostics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostate Cancer Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Prostate Cancer Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Prostate Cancer Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Related reports :

(Jul 19)

Scope of the Report: The global Pediatric Healthcare market is valued at xx million USD in 2018 and is expected to reach xx million U...

(Jul 19)

An electronic health record (EHR), or electronic medical record (EMR), is the systematized collection of patient and population electronical...

(Jul 19)

Referral management is the management of the process where referring providers search for the right specialist for a patient, choose one and...

(Jul 19)

The electrocardiogram (EKG) is the representation on paper of the electrical activity of the heart. This paper has certain essential charact...

(Jun 19)

Digital Pathology, which also refers as virtual microscopy, incorporates capturing, sharing, managing, interpreting and analysing the digita...

(Jun 19)

Scope of the Report: The global Push Telecommunications for Tele-Medicine (PTT) and M-Health market is valued at million USD in 2018 ...

GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Global Info Research

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Healthcare market as per your needs. Get the best of Healthcare research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

Avail 15% Discount, Use JULY15 Coupon Code

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy